Publication October 5, 2026

Bivalirudin Discussed in New ACS Guidelines Publication

A new publication referencing bivalirudin was released on October 5, 2026. The article, titled "Known Unknowns: Unpacking Controversies and Uncertainties in the 2025 Guidelines for Management of Acute Coronary Syndromes," appeared in Current Cardiology Reports.

The publication is listed under PubMed ID 42832065. It addresses topics described as controversies and uncertainties within the 2025 guidelines for managing acute coronary syndromes.

No specific findings, data, or conclusions from the publication have been provided beyond its title and journal placement. This brief does not summarize or interpret the content of the article itself, as that information was not included in the available event data.

Readers interested in acute coronary syndrome management guidelines may wish to consult the full text directly through the journal or PubMed listing for complete context on the discussion involving bivalirudin.

For general background on this compound, readers can refer to the compound overview.

See the full bivalirudin overview

Source: https://pubmed.ncbi.nlm.nih.gov/42832065/